Disclosure Of Interests In Other Entities [Text Block]

ABIONYX Pharma - Filing #2813091

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—		—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets	7 572 EUR	—	—	13 011 EUR	—	—
Non-current assets	8 251 EUR	—	—	8 821 EUR	—	—
Current liabilities	5 094 EUR	—	—	6 747 EUR	—	—
Non-current liabilities	3 560 EUR	—	—	4 408 EUR	—	—
Revenue	—	—	5 252 EUR	—	—	675,000 EUR
Profit (loss)	—	4 206 EUR	4 206 EUR	—	5 822 EUR	5 822 EUR
Comprehensive income	—	—	3 985 EUR	—	—	5 759 EUR
Disclosure of interests in associates [text block]	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	4 046 EUR	—	—	7 935 EUR	—	—
Other current financial liabilities	491,000 EUR	—	—	653,000 EUR	—	—
Interest expense	—	—	- EUR	—	—	- EUR